The Role of HMGB-1 in Chronic Stroke
Terminated
Phase N/A Results N/ASummary of Purpose
The purpose of this study is to measure the presence of HMGB-1 and other proteins in the blood across five time points after stroke, and to determine if their presence correlates with rate of stroke recovery. Trial Stopped: study stopped because patient access became extremely limited for the initial data entry point.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 9 March 2018.
1 Sep 2012 | 9 Oct 2012 | 1 Dec 2017 | 1 Feb 2018 | 1 Feb 2018 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Basics
Conditions
Sponsors
Trial Design
- Observation: Cohort
- Perspective: Prospective
- Sampling: Non-Probability Sample
Contacts
- Bruce T Volpe, MD
BVOLPE@burke.org (914)597-2835
- Johanna Chang, MS
jchang14@nshs.edu 516-562-3646
View Trial Locations
Recruitment
- Enrollment: 39
- Gender: All
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 2 locations, 1 country
Principal Investigator
- Bruce T Volpe, MD
BVOLPE@burke.org (914)597-2835